Spyre Therapeutics, Inc. (SYRE) SEC Filings — 2024

Filings

• Spyre Therapeutics Files 8-K with Material Agreement — 8-K · Nov 19, 2024
• Spyre Therapeutics Files 2023 10-K Amendment — 10-K/A · Nov 18, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Spyre Therapeutics Files 8-K, Formerly Aeglea BioTherapeutics — 8-K · Nov 12, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Spyre Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
• Spyre Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
• Spyre Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 23, 2024
• Spyre Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
• Spyre Therapeutics Enters Material Definitive Agreement — 8-K · Oct 15, 2024
• Spyre Therapeutics Files 8-K/A Amendment — 8-K/A · Aug 8, 2024
• Spyre Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Jun 10, 2024
• Spyre Therapeutics Files 8-K, Name Change Confirmed — 8-K · May 30, 2024
• Spyre Therapeutics Files 8-K with Material Agreements & Board Changes — 8-K · May 15, 2024
• Spyre Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Spyre Therapeutics Reports Unregistered Equity Sales — 8-K · Apr 25, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Apr 23, 2024
• Spyre Therapeutics, Inc. Files S-1 Registration Statement — S-1 · Apr 19, 2024
• Spyre Therapeutics DEF 14A: Executive Compensation Details — DEF 14A · Apr 1, 2024
• Spyre Therapeutics Files S-1/A Amendment — S-1/A · Mar 27, 2024
• Spyre Therapeutics Files 8-K with Key Corporate Updates — 8-K · Mar 18, 2024
• Spyre Therapeutics, Inc. Files S-1/A Amendment — S-1/A · Mar 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Mar 11, 2024
• Spyre Therapeutics, Inc. Files S-1/A Amendment — S-1/A · Mar 1, 2024
• Spyre Therapeutics Files 10-K/A Amendment for Fiscal Year 2023 — 10-K/A · Mar 1, 2024
• Spyre Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Spyre Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Spyre Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• FMR LLC & Abigail Johnson Hold 13.065% Stake in Spyre Therapeutics — SC 13G/A · Feb 12, 2024
• FMR LLC & Abigail Johnson Disclose 7.97% Stake in Spyre Therapeutics — SC 13G · Feb 9, 2024
• Millennium Management Amends Spyre Therapeutics Stake — SC 13G/A · Feb 8, 2024
• Spyre Therapeutics, Inc. Files S-1/A Amendment — S-1/A · Feb 5, 2024
• Spyre Therapeutics Receives Nasdaq Delisting Warning for Low Bid Price — 8-K · Jan 18, 2024